Skip to main content

Animations

MJFF Publications

6441 - 6450 of 8808 Results
Title
Year
  • Year
  • 2016
  • 2022
  • 2020
  • 2016
  • 2017
  • 2025
  • 2023
  • 2025
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24664
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28934
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-out
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcz052
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.025684
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0154-3
    Citation Count: 266
  • Summary Details
    RESTRICTED
    Title: A validation study of the Clinician's Tardive Inventory (CTI)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107812
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00604-y
    Citation Count: 38
  • Summary Details
    OPEN
    Title: CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adu0726
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27385
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum
    Journal Name: ACS Central Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acscentsci.8b00879
    Citation Count: 146
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.